...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: TD Waterhouse-TFSA

I editted my post but it didn't add the following...

Hopefully, the information is contained in the Sedar and you should be able to follow up with your institution and the CRA - good luck.

Please Note:  This is not intended as investment advice - Please do your own due dilgence.  :)

Long

Share
New Message
Please login to post a reply